References
Abdelghani, M., Hamed, M. G., Said, A., & Fouad, E. (2022). Evaluation of perceived fears of COVID-19 virus infection and its relationship to health-related quality of life among patients with diabetes mellitus in Egypt during pandemic: a developing country single-center study. Diabetology international, 13(1), 108-116.
Acter, T., Uddin, N., Das, J., Akhter, A., Choudhury, T. R., & Kim, S. (2020). Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency. Science of the Total Environment, 730, 138996.
Al-Jandeel, T. J., Al-Karawi, A. S., Abdulrazzaq, O. I., & Tareq, S. (2023). An Evaluation of Laboratory Tests for COVID-19 Infection in Patients Residing in the Baghdad-Iraq. International Journal of Chemical and Biochemical Sciences, 23(1).
Al-Taie, A., Arueyingho, O., Khoshnaw, J., & Hafeez, A. (2022). Clinical outcomes of multidimensional association of type 2 diabetes mellitus, COVID-19 and sarcopenia: an algorithm and scoping systematic evaluation. Archives of Physiology and Biochemistry, 1-19.
Bahmer, T., Borzikowsky, C., Lieb, W., Horn, A., Krist, L., Fricke, J., Scheibenbogen, C., Rabe, K. F., Maetzler, W., & Maetzler, C. (2022). Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study. EClinicalMedicine, 51.
Bouayed, J., & Bohn, T. (2021). The link between microglia and the severity of COVID-19: The “two-hit” hypothesis. Journal of medical virology, 93(7), 4111.
Burtscher, J., Millet, G. P., Fresa, M., Lanzi, S., Mazzolai, L., & Pellegrin, M. (2023). The link between impaired oxygen supply and cognitive decline in peripheral artery disease. Progress in Cardiovascular Diseases.
Chen, J., Hall, S., & Vitetta, L. (2021). Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19. Reviews in medical virology, 31(5), 1-13.
Conte, C., Cipponeri, E., & Roden, M. (2024). Diabetes Mellitus, Energy Metabolism, and COVID-19. Endocrine reviews, 45(2), 281-308.
Crook, H., Raza, S., Nowell, J., Young, M., & Edison, P. (2021). Long covid—mechanisms, risk factors, and management. Bmj, 374.
Deng, J., Wang, R., Huang, S., Ding, J., & Zhou, W. (2023). Macrophages-regulating nanomedicines for sepsis therapy. Chinese Chemical Letters, 34(3), 107588.
Drucker, D. J. (2020). Coronavirus infections and type 2 diabetes—shared pathways with therapeutic implications. Endocrine reviews, 41(3), bnaa011.
Erener, S. (2020). Diabetes, infection risk and COVID-19. Molecular metabolism, 39, 101044.
Fernández-de-Las-Peñas, C., Guijarro, C., Torres-Macho, J., Velasco-Arribas, M., Plaza-Canteli, S., Hernández-Barrera, V., & Arias-Navalón, J. A. (2021). Diabetes and the risk of long-term post-COVID symptoms. Diabetes, 70(12), 2917-2921.
Gregory, J. M., Slaughter, J. C., Duffus, S. H., Smith, T. J., LeStourgeon, L. M., Jaser, S. S., McCoy, A. B., Luther, J. M., Giovannetti, E. R., & Boeder, S. (2021). COVID-19 severity is tripled in the diabetes community: a prospective analysis of the pandemic’s impact in type 1 and type 2 diabetes. Diabetes care, 44(2), 526-532.
Gavali, L. V., Mohammed, A. A., Al-Ogaili, M. J., Gaikwad, S. H., Kulkarni, M., Das, R., & Ubale, P. A. (2024). Novel terephthalaldehyde bis (thiosemicarbazone) Schiff base ligand and its transition metal complexes as antibacterial Agents: Synthesis, characterization and biological investigations. Results in Chemistry, 7, 101316.
Harrop, C., Bal, V., Carpenter, K., & Halladay, A. (2021). A lost generation? The impact of the COVID-19 pandemic on early career ASD researchers. Autism research, 14(6), 1078-1087.
Ip, C., Luk, K. S., Yuen, V. L. C., Chiang, L., Chan, C. K., Ho, K., Gong, M., Lee, T. T. L., Leung, K. S. K., & Roever, L. (2021). Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: A systematic review and meta-analysis. IJC Heart & Vasculature, 37, 100887.
Maxmen, A., & Mallapaty, S. (2021). The COVID lab-leak hypothesis: what scientists do and don’t know. Nature, 594(7863), 313-315.
Mundula, T., Russo, E., Curini, L., Giudici, F., Piccioni, A., Franceschi, F., & Amedei, A. (2022). Chronic systemic low-grade inflammation and modern lifestyle: The dark role of gut microbiota on related diseases with a focus on COVID-19 pandemic. Current medicinal chemistry, 29(33), 5370-5396.
Nanchal, R., Subramanian, R., Karvellas, C. J., Hollenberg, S. M., Peppard, W. J., Singbartl, K., Truwit, J., Al-Khafaji, A. H., Killian, A. J., & Alquraini, M. (2020). Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU: cardiovascular, endocrine, hematologic, pulmonary, and renal considerations. Critical care medicine, 48(3), e173-e191.
Ngo, V. L., & Gewirtz, A. T. (2021). Microbiota as a potentially-modifiable factor influencing COVID-19. Current Opinion in Virology, 49, 21-26.
Nguyen, C., Parson, H. K., Pettaway, J., Ingram, A., Sears, T., Bard, J. T., Forte, S., Wintringham, J. A., Vinik, E., & Siraj, E. S. (2023). Utilizing a quality of life tool to examine the presence of fatigue in subjects with diabetes mellitus. Journal of Clinical & Translational Endocrinology, 34, 100328.
O'Kelly, B., Vidal, L., Avramovic, G., Broughan, J., Connolly, S. P., Cotter, A. G., Cullen, W., Glaspy, S., McHugh, T., & Woo, J. (2022). Assessing the impact of COVID-19 at 1-year using the SF-12 questionnaire: data from the anticipate longitudinal cohort study. International Journal of Infectious Diseases, 118, 236-243.
Pan, M., Vasbinder, A., Anderson, E., Catalan, T., Shadid, H. R., Berlin, H., Padalia, K., O’hayer, P., Meloche, C., & Azam, T. U. (2021). Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and outcomes in patients hospitalized for COVID-19. Journal of the American Heart Association, 10(24), e023535.
Pazoki, M., Keykhaei, M., Kafan, S., Montazeri, M., Mirabdolhagh Hazaveh, M., Sotoodehnia, M., Kazemian, S., Talebpour, M., Ashraf, H., & Shariat Moharari, R. (2021). Risk indicators associated with in-hospital mortality and severity in patients with diabetes mellitus and confirmed or clinically suspected COVID-19. Journal of Diabetes & Metabolic Disorders, 20, 59-69.
Pereko, K. K. A., Mensah, E. D., Acquaye, V. A., Nsiah-Asamoah, C., Chadare, F., Intiful, F. D., Setorglo, J., Ebu, N. I., & Dai-Kosi, A. D. (2021). The role of nutrition in respiratory disease and COVID-19 management. In Mental Health Effects of COVID-19 (pp. 187-213). Elsevier.
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M., Anto, J. M., Arcolaci, A., Azkur, A. K., & Azkur, D. (2020). A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy, 75(10), 2503-2541.
Roberts, J., Pritchard, A. L., Treweeke, A. T., Rossi, A. G., Brace, N., Cahill, P., MacRury, S. M., Wei, J., & Megson, I. L. (2021). Why is COVID-19 more severe in patients with diabetes? The role of angiotensin-converting enzyme 2, endothelial dysfunction and the immunoinflammatory system. Frontiers in Cardiovascular Medicine, 7, 629933.
Rout, D., & Sahoo, A. K. (2023). Clinical implications of a mechanistic link connecting SARS-Cov-2, diabetes mellitus, Zinc in COVID-19 pathophysiology, and the prophylactics in the treatment of SARS-CoV-2. European Journal of Medicinal Chemistry Reports, 100117.
Seeßle, J., Waterboer, T., Hippchen, T., Simon, J., Kirchner, M., Lim, A., Müller, B., & Merle, U. (2022). Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clinical Infectious Diseases, 74(7), 1191-1198.
Steenblock, C., Hassanein, M., Khan, E. G., Yaman, M., Kamel, M., Barbir, M., Lorke, D. E., Rock, J. A., Everett, D., & Bejtullah, S. (2022). Diabetes and COVID-19: short-and long-term consequences. Hormone and Metabolic Research, 54(08), 503-509.
Troncone, A., Cascella, C., Chianese, A., Zanfardino, A., Pizzini, B., & Iafusco, D. (2023). Psychological consequences of the COVID-19 pandemic in people with type 1 diabetes: a systematic literature review. Journal of psychosomatic research, 168, 111206.
Vasbinder, A., Anderson, E., Shadid, H., Berlin, H., Pan, M., Azam, T. U., Khaleel, I., Padalia, K., Meloche, C., & O’hayer, P. (2022). Inflammation, hyperglycemia, and adverse outcomes in individuals with diabetes mellitus hospitalized for COVID-19. Diabetes care, 45(3), 692-700.
Zhou, Z., Wang, H., Tan, S., Zhang, H., & Zhu, Y. (2024). The alterations of innate immunity and enhanced severity of infections in diabetes mellitus. Immunology, 171(3), 313-323.